EGFR Positive Lung Cancer UK
EGFR Positive UK works to promote the needs of EGFR mutation positive lung cancer patients across the UK.
Objects
THE OBJECT OF THE CIO IS:TO PRESERVE AND PROTECT THE GOOD HEALTH OF UK EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POSITIVE LUNG CANCER PATIENTS BY:- A. PROVIDING AN INFORMATION RESOURCE, IN PARTICULAR ACCESS TO INFORMATION ABOUT LATEST DEVELOPMENTS AND CLINICAL TRIALS; B. IDENTIFYING AND LOCATING UK EGFR PATIENTS AND OFFERING SUPPORT AND GUIDANCE ON THE LOCATION OF UK EGFR SPECIALISTS AND SERVICES;C. LIAISING WITH AND INFLUENCING DECISION MAKERS, E.G. NICE, NHS, DVLA; D. RAISING AWARENESS OF EGFR LUNG CANCER, PARTICULARLY AMONGST THE MEDICAL PROFESSION SO AS TO PROMOTE THE BEST TREATMENT FOR PATIENTS; E. LIAISING WITH RELEVANT ORGANISATIONS, IN PARTICULAR ROY CASTLE LUNG CANCER FOUNDATION AND THE PHARMACEUTICAL INDUSTRY; F. RAISING FUNDS FOR THE ABOVE PURPOSES.
Financial health, per its FY2025 accounts
The accounts state that total receipts for the year were £88,938, with a general surplus of £13,712 added to reserves. The charity holds £24,502 in bank and £70,108 in fixed deposits, while restricted funds of £18,212 are held for a specific project. The trustees report that the charity does not employ staff and has low fixed costs.
What the accounts disclose
“88% came from fundraising and an additional £ 19,169 from Gift Aid”
Policies the charity declares
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Investing charity funds policy and procedures
- Investment
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
Trustees
- Nicola Cowlandchair
- Charlotte Judyth Maxwell
- Dr Virginia Mary Harrison
- Elizabeth Lucy Baker
- Ismet Jabeen Sadiq-Shirley
- Soumitra Bose Treasurer
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £89k | £57k |
| 31/03/2024 | £59k | £51k |
| 31/03/2023 | £23k | £10k |
| 31/03/2022 | £38k | £1k |
| 31/03/2021 | £3k | £0 |
Common questions
Is EGFR Positive Lung Cancer UK financially healthy?
Per its FY2025 accounts: The accounts state that total receipts for the year were £88,938, with a general surplus of £13,712 added to reserves. The charity holds £24,502 in bank and £70,108 in fixed deposits, while restricted funds of £18,212 are held for a specific project. The trustees report that the charity does not employ staff and has low fixed costs.